The decision in a lawsuit involving Insulet’s Omnipod insulin pumps provides a vivid reminder on the value of trade secrets and the need to protect them.
IP
Increased Scamming on US Trademarks
Scammers are now calling US trademark owners and either offering services that are not needed or pretending to be the United States Patent and Trademark Office (USPTO) and requesting payment.
New IP Resources Added
From trademarks and trade secrets to copyrights, patents and licensing, our expert attorneys provide legal counsel and guidance on IP matters.
Should AI be Recognized as an Inventor on Patents?
The intersection of artificial intelligence (AI) and intellectual property raises many legal questions – and the answers aren’t yet clearly defined.
What’s in a Name? The Prince Brand Lives On
In addition to trademarking his name symbol, Prince’s song “Purple Rain” was the subject of legal action.
Michael Antone to Host IP Webinar
Join us for an upcoming webinar: The Entrepreneur’s Guide to Intellectual Property – Trademarks, Copyrights, Patents and More.
Intellectual Property Trivia
Think you know IP? Test your intellectual property knowledge with IP trivia and interesting tidbits about copyrights, trademarks, patents and more.
Michael Antone Shares IP Info for Entrepreneurs
In launching your business, imagine having all your hard work mitigated by one misstep – not protecting your intellectual property. Michael Antone’s recent article in Maryland Inno provides important info for entrepreneurs.
Latest Insights
View All
CTA Update: New Deadline Now in Effect
BOI reporting requirements under the CTA are back in effect. The new deadline for most reporting companies is now March 21, 2025.
Trade Secrets and MedTech: IP in the News
The decision in a lawsuit involving Insulet’s Omnipod insulin pumps provides a vivid reminder on the value of trade secrets and the need to protect them.
MedTech M&A is Poised for Growth
In MedTech Dive, Nemphos Braue highlights 5 reasons why healthcare mergers, acquisitions, JVs and other transactions – especially in the MedTech space – are poised to increase.
